AN2 THERAPEUTICS INC (ANTX)

US0373261058 - Common Stock

2.56  +0.02 (+0.79%)

After market: 2.56 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
69.64M42.26M21.57M7.28M5.18M
Research and Development
54.87M29.51M16.91M6.02M4.89M
Selling, General, and Administrative Expenses
14.76M12.75M4.67M1.27M290.00K
Operating Income
-69.64M-42.26M-21.57M-7.28M-5.18M
Interest Income/Expense
N/A1.35M70.00K0.000.00
Other Income/Expense
4.90M-50.00K-40.00K-6.32M-460.00K
Income Before Taxes
-64.73M-40.96M-21.54M-13.60M-5.64M
Net Income
-64.73M-42.78M-28.06M-14.58M-5.73M
 
Per Share Data
EPS Diluted Total Ops
-2.74-2.79-1.50-0.78-0.31
Non GAAP EPS
-2.82-4.71N/AN/AN/A
 
Statistics

All data in USD

Charts